Novel Technique for Cell Cultures in Gynecologic Oncology

Overview

About this study

The purpose of this study is to develop cell cultures specifically for the study of gynecological carcinomas using in vivo zebrafish tissue modeling, and to  establish a robust and reliable assay for predicting response to treatment on an individualized basis for Mayo Clinic cancer patients.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  1. Preoperative diagnosis of gynecological cancer,
  2. Age ≥ 18
  3. Able to give informed consent

 

Exclusion Criteria

  1. Patients submitted to neoadjuvant chemotherapy
  2. Previous radiation therapy
  3. Synchronous cancer

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Amanika Kumar, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available
.
CLS-20436943

Mayo Clinic Footer